Delivery Order SPE2DB22D9367-SPE2DB24FSY70

Award Date 7/11/24
Potential Completion Date 8/1/24
Potential Value $56K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $98,449.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of 4,566,883,558 units of the oncology medication Keytruda (100 mg/4 ml vial, 4 ml) and has an ultimate completion date of January 28, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $48,131.04, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials by May 9, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 contract is to provide Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
The U.S. Defense Logistics Agency (DLA) has awarded a $77,505.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,560,580,827 units of Keytruda 100 mg/4 ml vial, a cancer medication, with a performance period ending on May 3, 2023. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a $40,142.85 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract provides the Keytruda 100 mg/4 ml vial medication, with a period of performance running through May 14, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $127,565.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Keytruda 100 mg/4 ml vials, a cancer medication, with a period of performance through October 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $16,057.14 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $48,171.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $24,065.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, an oncology medication, with a period of performance through December 10, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is not set-aside, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY70
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $56,199.99 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 held by DMS Pharmaceutical Group to provide a wide range of pharmaceutical items, including branded and generic drugs, biologics, and medical supplies, to support the recurring medical needs of military health facilities worldwide. The order is for the oncology drug Keytruda 100 mg/4 ml vial with an ultimate completion date of August 1, 2024. This contract was awarded without any set-aside designation.

Generated 10/10/24, 9:23 AM